166480 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
CORESTEMCHEMON, Inc. engages in the development and distribution of gene therapy products. The company was founded on December 29, 2003 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
166480 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company